Evidence for a multipotent mammary progenitor with pregnancy-specific activity

Breast Cancer Research

Volumn 15, Issue 4, 2013, Pages

  Kaanta, Alice S ^a   Virtanen, Carl ^b   Selfors, Laura M ^a   Brugge, Joan S ^a   Neel, Benjamin G ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

H2BGFP; Mammary progenitors; Mammary stem cells; MMTVrtTA; Pregnancy

Indexed keywords

AMPHIREGULIN; BETA1 INTEGRIN; BETA3 INTEGRIN; CAVEOLIN 1; CD24 ANTIGEN; DOXYCYCLINE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GLUCOCORTICOID RECEPTOR; GREEN FLUORESCENT PROTEIN; HISTONE H2B; MESSENGER RNA; MUCIN 1; PROGESTERONE RECEPTOR; PROLACTIN RECEPTOR; ROUNDABOUT RECEPTOR; STEROID RECEPTOR; TETRACYCLINE; WNT5A PROTEIN; BIOLOGICAL MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST EPITHELIUM; CELL SUSPENSION; CONTROLLED STUDY; DEVELOPMENTAL GENE; FEMALE; FLOW CYTOMETRY; FUSION GENE; GENE EXPRESSION; GENOTYPE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MAMMARY GLAND; MICROARRAY ANALYSIS; MILK; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; MULTIPOTENT MAMMARY PROGENITOR CELL; MULTIPOTENT STEM CELL; MYOEPITHELIUM; NONHUMAN; PREGNANCY; PROMOTER REGION; PROTEIN EXPRESSION; TRANSGENE; TRANSGENIC MOUSE; TRANSPLANTATION; ANIMAL; CELL DIFFERENTIATION; CELL LINEAGE; CLUSTER ANALYSIS; CYTOLOGY; GENE EXPRESSION PROFILING; IMMUNOPHENOTYPING; METABOLISM; PHENOTYPE; REPORTER GENE; UDDER;

ANIMALS; ANTIGENS, CD24; ANTIGENS, CD29; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINEAGE; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENES, REPORTER; IMMUNOPHENOTYPING; MAMMARY GLANDS, ANIMAL; MICE; MICE, TRANSGENIC; MULTIPOTENT STEM CELLS; PHENOTYPE; PREGNANCY;

EID: 84881449377     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3459     Document Type: Article

References (43)

1. Cole H. The mammary gland of the mouse, during oestrus cycle, pregnancy and lactation. Proc R Soc London: Biol Sci 1933, 114:136-161.
2. Tiede B, Kang Y. From milk to malignancy: the role of mammary stem cells in development, pregnancy and breast cancer. Cell Res 2011, 21:245-257. 10.1038/cr.2011.11, 3193434, 21243011.
3. Hennighausen L, Robinson GW. Signaling pathways in mammary gland development. Dev Cell 2001, 1:467-475. 10.1016/S1534-5807(01)00064-8, 11703938.
4. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, Visvader JE. Generation of a functional mammary gland from a single stem cell. Nature 2006, 439:84-88. 10.1038/nature04372, 16397499.
5. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, Li HI, Eaves CJ. Purification and unique properties of mammary epithelial stem cells. Nature 2006, 439:993-997.
6. Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, Hartley L, Robb L, Grosveld FG, van der Wees J, Lindeman GJ, Visvader JE. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 2007, 9:201-209. 10.1038/ncb1530, 17187062.
7. Li W, Ferguson BJ, Khaled WT, Tevendale M, Stingl J, Poli V, Rich T, Salomoni P, Watson CJ. PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool. Proc Natl Acad Sci U S A 2009, 106:4725-4730. 10.1073/pnas.0807640106, 2660741, 19261859.
8. Asselin-Labat ML, Sutherland KD, Vaillant F, Gyorki DE, Wu D, Holroyd S, Breslin K, Ward T, Shi W, Bath ML, Deb S, Fox SB, Smyth GK, Lindeman GJ, Visvader JE. Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14. Mol Cell Biol 2011, 31:4609-4622. 10.1128/MCB.05766-11, 3209243, 21930782.
9. Stingl J. Detection and analysis of mammary gland stem cells. J Pathol 2009, 217:229-241. 10.1002/path.2457, 19009588.
10. Vaillant F, Lindeman GJ, Visvader JE. Jekyll or Hyde: does Matrigel provide a more or less physiological environment in mammary repopulating assays?. Breast Cancer Res 2011, 13:108. 10.1186/bcr2851, 3218928, 21635708.
11. Jeselsohn R, Brown NE, Arendt L, Klebba I, Hu MG, Kuperwasser C, Hinds PW. Cyclin D1 kinase activity is required for the self-renewal of mammary stem and progenitor cells that are targets of MMTV-ErbB2 tumorigenesis. Cancer Cell 2010, 17:65-76. 10.1016/j.ccr.2009.11.024, 2818730, 20129248.
12. Smith GH. Experimental mammary epithelial morphogenesis in an in vivo model: evidence for distinct cellular progenitors of the ductal and lobular phenotype. Breast Cancer Res Treat 1996, 39:21-31. 10.1007/BF01806075, 8738603.
13. Sleeman KE, Kendrick H, Ashworth A, Isacke CM, Smalley MJ. CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells. Breast Cancer Res 2006, 8:R7. 10.1186/bcr1371, 1413978, 16417656.
14. Van Keymeulen A, Rocha AS, Ousset M, Beck B, Bouvencourt G, Rock J, Sharma N, Dekoninck S, Blanpain C. Distinct stem cells contribute to mammary gland development and maintenance. Nature 2011, 479:189-193. 10.1038/nature10573, 21983963.
15. Smith GH. Label-retaining epithelial cells in mouse mammary gland divide asymmetrically and retain their template DNA strands. Development 2005, 132:681-687. 10.1242/dev.01609, 15647322.
16. Booth BW, Smith GH. Estrogen receptor-alpha and progesterone receptor are expressed in label-retaining mammary epithelial cells that divide asymmetrically and retain their template DNA strands. Breast Cancer Res 2006, 8:R49. 10.1186/bcr1538, 1779481, 16882347.
17. Booth BW, Boulanger CA, Smith GH. Selective segregation of DNA strands persists in long-label-retaining mammary cells during pregnancy. Breast Cancer Res 2008, 10:R90. 10.1186/bcr2188, 2614527, 18950502.
18. Tumbar T, Guasch G, Greco V, Blanpain C, Lowry WE, Rendl M, Fuchs E. Defining the epithelial stem cell niche in skin. Science 2004, 303:359-363. 10.1126/science.1092436, 2405920, 14671312.
19. Foudi A, Hochedlinger K, Van Buren D, Schindler JW, Jaenisch R, Carey V, Hock H. Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells. Nat Biotechnol 2009, 27:84-90. 10.1038/nbt.1517, 2805441, 19060879.
20. Dos Santos CO, Rebbeck C, Rozhkova E, Valentine A, Samuels A, Kadiri LR, Osten P, Harris EY, Uren PJ, Smith AD, Hannon GJ. Molecular hierarchy of mammary differentiation yields refined markers of mammary stem cells. Proc Natl Acad Sci U S A 2013, 110:7123-7130. 10.1073/pnas.1303919110, 3645536, 23580620.
21. Gunther EJ, Belka GK, Wertheim GB, Wang J, Hartman JL, Boxer RB, Chodosh LA. A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology. FASEB J 2002, 16:283-292. 10.1096/fj.01-0551com, 11874978.
22. Ip MM, Asch BB. Methods in mammary gland biology and breast cancer research 2000, New York: Kluwer Academic/Plenum Publishers.
23. Hu Y, Smyth GK. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 2009, 347:70-78. 10.1016/j.jim.2009.06.008, 19567251.
24. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5:R80. 10.1186/gb-2004-5-10-r80, 545600, 15461798.
25. Du P, Kibbe WA, Lin SM. Lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008, 24:1547-1548. 10.1093/bioinformatics/btn224, 18467348.
26. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007, 8:118-127. 10.1093/biostatistics/kxj037, 16632515.
27. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B (Methodological) 1995, 57:289-300.
28. Vaillant F, Asselin-Labat ML, Shackleton M, Forrest NC, Lindeman GJ, Visvader JE. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res 2008, 68:7711-7717. 10.1158/0008-5472.CAN-08-1949, 18829523.
29. Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003, 30:256-268. 10.1016/S1046-2023(03)00032-X, 12798140.
30. Fuchs E, Tumbar T, Guasch G. Socializing with the neighbors: stem cells and their niche. Cell 2004, 116:769-778. 10.1016/S0092-8674(04)00255-7, 15035980.
31. Asselin-Labat ML, Shackleton M, Stingl J, Vaillant F, Forrest NC, Eaves CJ, Visvader JE, Lindeman GJ. Steroid hormone receptor status of mouse mammary stem cells. J Natl Cancer Inst 2006, 98:1011-1014. 10.1093/jnci/djj267, 16849684.
32. Wintermantel TM, Bock D, Fleig V, Greiner EF, Schutz G. The epithelial glucocorticoid receptor is required for the normal timing of cell proliferation during mammary lobuloalveolar development but is dispensable for milk production. Mol Endocrinol 2005, 19:340-349.
33. Bonnefoix T, Bonnefoix P, Verdiel P, Sotto JJ. Fitting limiting dilution experiments with generalized linear models results in a test of the single-hit Poisson assumption. J Immunol Methods 1996, 194:113-119. 10.1016/0022-1759(96)00077-4, 8765164.
34. Fazekas de St G. The evaluation of limiting dilution assays. J Immunol Methods 1982, 49:R11-R23. 10.1016/0022-1759(82)90269-1, 7040548.
35. Bryder D, Rossi DJ, Weissman IL. Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Pathol 2006, 169:338-346. 10.2353/ajpath.2006.060312, 1698791, 16877336.
36. Lim E, Wu D, Pal B, Bouras T, Asselin-Labat ML, Vaillant F, Yagita H, Lindeman GJ, Smyth GK, Visvader JE. Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res 2010, 12:R21. 10.1186/bcr2560, 2879567, 20346151.
37. Joshi PA, Jackson HW, Beristain AG, Di Grappa MA, Mote PA, Clarke CL, Stingl J, Waterhouse PD, Khokha R. Progesterone induces adult mammary stem cell expansion. Nature 2010, 465:803-807. 10.1038/nature09091, 20445538.
38. Asselin-Labat ML, Vaillant F, Sheridan JM, Pal B, Wu D, Simpson ER, Yasuda H, Smyth GK, Martin TJ, Lindeman GJ, Visvader JE. Control of mammary stem cell function by steroid hormone signalling. Nature 2010, 465:798-802. 10.1038/nature09027, 20383121.
39. Chepko G, Smith GH. Three division-competent, structurally-distinct cell populations contribute to murine mammary epithelial renewal. Tissue Cell 1997, 29:239-253. 10.1016/S0040-8166(97)80024-9, 9149446.
40. Wagner KU, Boulanger CA, Henry MD, Sgagias M, Hennighausen L, Smith GH. An adjunct mammary epithelial cell population in parous females: its role in functional adaptation and tissue renewal. Development 2002, 129:1377-1386.
41. Boulanger CA, Wagner KU, Smith GH. Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-beta1 expression. Oncogene 2005, 24:552-560. 10.1038/sj.onc.1208185, 15580303.
42. Matulka LA, Triplett AA, Wagner KU. Parity-induced mammary epithelial cells are multipotent and express cell surface markers associated with stem cells. Dev Biol 2007, 303:29-44. 10.1016/j.ydbio.2006.12.017, 17222404.
43. Spike BT, Engle DD, Lin JC, Cheung SK, La J, Wahl GM. A mammary stem cell population identified and characterized in late embryogenesis reveals similarities to human breast cancer. Cell Stem Cell 2012, 10:183-197. 10.1016/j.stem.2011.12.018, 3277444, 22305568.